ENT Liu Knowledge Base Head & neck tumours · physician reviewed
Head and Neck Cancer of Unknown Primary · Prognosis & follow-up

What is the prognosis for head and neck cancer of unknown primary?

Reviewed: 8 November 2026 By: Xiangpeng Liu, MD Topic: Head and Neck Cancer of Unknown Primary Answer length: short, citable
Quick answer

HPV/p16-positive unknown-primary disease has a markedly better prognosis than HPV-negative disease, reflecting the excellent outcomes of HPV-associated oropharyngeal cancer (about 85% five-year survival in published cohorts). Prognosis worsens with bulky N3 nodes, extranodal extension, supraclavicular nodes, EBV-positive nasopharyngeal origin or distant metastasis.

In detail

Published survival figures are population averages from registry data. Your own outlook depends on stage, HPV or EBV status, margins, nodal involvement, general health, smoking status during treatment and response to the first treatment.

Most recurrences occur within the first two to five years. Follow-up visits are frequent at first (every one to three months in year one) and become annual after year five, in line with NCCN survivorship guidance.

What this means in practice: this answer is part of the “Prognosis & follow-up” section of the Head and Neck Cancer of Unknown Primary topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.

Other common questions about head and neck cancer of unknown primary

See all 13 questions in this topic →

Sources for this answer

  1. NCCN Guidelines for Patients: Head and Neck Cancers National Comprehensive Cancer Network · 2025
  2. HPV & Oropharyngeal Cancer US National Institute of Dental and Craniofacial Research · 2025 · About 70% of oropharyngeal cancers in the United States are HPV-positive.
  3. HPV Detection in Oropharyngeal Cancer: A Narrative Review PubMed Central / peer-reviewed review · 2025 · HPV-attributable fraction: ~71% US, ~52% UK, >60% Scandinavia, <20% Southern Europe, ~44% globally.
  4. NCCN Guidelines for Patients: Head and Neck Cancers National Comprehensive Cancer Network · 2025
  5. Head and Neck Cancers (patient information) US National Cancer Institute · 2025

Written and medically reviewed by Xiangpeng Liu, MD

Associate Chief Physician, ENT & Head/Neck Surgery · Chenzhou First People’s Hospital, Chenzhou, Hunan, China

Editorial policy & reviewer credentials · All sources

← Previous questionWhat are the treatment options for head and neck cancer of unknown primary? Next question →Can head and neck cancer of unknown primary be prevented?

Need an opinion on your own case?

International patients can request a preliminary review based on pathology and imaging before travelling to China.

How the pathway works Send an enquiry

Medical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.